ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹18.49
Market cap: ₹43.84 Cr
Revenue (annual): ₹92.74 Cr
Net profit (annual): ₹4.96 Cr
P/E (TTM): 5.7×Sector 43.8×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 Nov 2026 19:11 IST BSE

Financial Results

Kabra Drugs Q2 FY27 Results: Net Profit ₹1.9 Cr, Up 5.6% YoY

Kabra Drugs Ltd reported revenue from operations of ₹32 Cr (+61.6% YoY) and net profit of ₹1.9 Cr (+5.6% YoY) for Q2 FY27.

Key figure: Net profit ₹1.9 Cr · +5.6% YoY

Open full results → Read the filing ↗

Kabra Drugs Ltd by type